The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors

Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dennis M. Timmerman, Thomas F. Eleveld, Ad J. M. Gillis, Carlijn C. Friedrichs, Sanne Hillenius, Tessa L. Remmers, Sruthi Sriram, Leendert H. J. Looijenga
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e3ff7794ad124071bdac71a905542ee0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e3ff7794ad124071bdac71a905542ee0
record_format dspace
spelling oai:doaj.org-article:e3ff7794ad124071bdac71a905542ee02021-11-11T17:14:01ZThe Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors10.3390/ijms2221117741422-00671661-6596https://doaj.org/article/e3ff7794ad124071bdac71a905542ee02021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11774https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum show a worse response, which remains largely unexplained. Here, we address the differences among GCTs from two different anatomical locations (testicular versus mediastinal/extragonadal), with a specific focus on the role of the P53 pathway. It was recently shown that GCTs with <i>TP53</i> mutations most often localize to the mediastinum. To elucidate the underlying mechanism, <i>TP53</i> knock-out lines were generated in cisplatin-sensitive and -resistant clones of the representative 2102Ep cell line (wild-type <i>TP53</i> testicular GCT) and NCCIT cell line (hemizygously mutated <i>TP53</i>, mutant <i>TP53</i> mediastinal GCT). The full knock-out of <i>TP53</i> in 2102Ep and resistant NCCIT resulted in an increase in cisplatin resistance, suggesting a contributing role for P53, even in NCCIT, in which P53 had been reported to be non-functional. In conclusion, these results suggest that <i>TP53</i> mutations contribute to the cisplatin-resistant phenotype of mediastinal GCTs and, therefore, are a potential candidate for targeted treatment. This knowledge provides a novel model system to elucidate the underlying mechanism of clinical behavior and possible alternative treatment of the <i>TP53</i> mutant and mediastinal GCTs.Dennis M. TimmermanThomas F. EleveldAd J. M. GillisCarlijn C. FriedrichsSanne HilleniusTessa L. RemmersSruthi SriramLeendert H. J. LooijengaMDPI AGarticlehuman malignant germ cell tumorsmediastinal germ cell tumorstesticular germ cell tumorscisplatin resistance<i>TP53</i>NCCITBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11774, p 11774 (2021)
institution DOAJ
collection DOAJ
language EN
topic human malignant germ cell tumors
mediastinal germ cell tumors
testicular germ cell tumors
cisplatin resistance
<i>TP53</i>
NCCIT
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle human malignant germ cell tumors
mediastinal germ cell tumors
testicular germ cell tumors
cisplatin resistance
<i>TP53</i>
NCCIT
Biology (General)
QH301-705.5
Chemistry
QD1-999
Dennis M. Timmerman
Thomas F. Eleveld
Ad J. M. Gillis
Carlijn C. Friedrichs
Sanne Hillenius
Tessa L. Remmers
Sruthi Sriram
Leendert H. J. Looijenga
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
description Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum show a worse response, which remains largely unexplained. Here, we address the differences among GCTs from two different anatomical locations (testicular versus mediastinal/extragonadal), with a specific focus on the role of the P53 pathway. It was recently shown that GCTs with <i>TP53</i> mutations most often localize to the mediastinum. To elucidate the underlying mechanism, <i>TP53</i> knock-out lines were generated in cisplatin-sensitive and -resistant clones of the representative 2102Ep cell line (wild-type <i>TP53</i> testicular GCT) and NCCIT cell line (hemizygously mutated <i>TP53</i>, mutant <i>TP53</i> mediastinal GCT). The full knock-out of <i>TP53</i> in 2102Ep and resistant NCCIT resulted in an increase in cisplatin resistance, suggesting a contributing role for P53, even in NCCIT, in which P53 had been reported to be non-functional. In conclusion, these results suggest that <i>TP53</i> mutations contribute to the cisplatin-resistant phenotype of mediastinal GCTs and, therefore, are a potential candidate for targeted treatment. This knowledge provides a novel model system to elucidate the underlying mechanism of clinical behavior and possible alternative treatment of the <i>TP53</i> mutant and mediastinal GCTs.
format article
author Dennis M. Timmerman
Thomas F. Eleveld
Ad J. M. Gillis
Carlijn C. Friedrichs
Sanne Hillenius
Tessa L. Remmers
Sruthi Sriram
Leendert H. J. Looijenga
author_facet Dennis M. Timmerman
Thomas F. Eleveld
Ad J. M. Gillis
Carlijn C. Friedrichs
Sanne Hillenius
Tessa L. Remmers
Sruthi Sriram
Leendert H. J. Looijenga
author_sort Dennis M. Timmerman
title The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
title_short The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
title_full The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
title_fullStr The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
title_full_unstemmed The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
title_sort role of <i>tp53</i> in cisplatin resistance in mediastinal and testicular germ cell tumors
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e3ff7794ad124071bdac71a905542ee0
work_keys_str_mv AT dennismtimmerman theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT thomasfeleveld theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT adjmgillis theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT carlijncfriedrichs theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT sannehillenius theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT tessalremmers theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT sruthisriram theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT leenderthjlooijenga theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT dennismtimmerman roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT thomasfeleveld roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT adjmgillis roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT carlijncfriedrichs roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT sannehillenius roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT tessalremmers roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT sruthisriram roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
AT leenderthjlooijenga roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors
_version_ 1718432150616801280